Cargando…
Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells
BACKGROUND: In physiological conditions, it is postulated that neurons control microglial reactivity through a series of inhibitory mechanisms, involving either cell contact-dependent, soluble-factor-dependent or neurotransmitter-associated pathways. In the current study, we focus on CD200R1, a micr...
Autores principales: | Dentesano, Guido, Straccia, Marco, Ejarque-Ortiz, Aroa, Tusell, Josep M, Serratosa, Joan, Saura, Josep, Solà, Carme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414764/ https://www.ncbi.nlm.nih.gov/pubmed/22776069 http://dx.doi.org/10.1186/1742-2094-9-165 |
Ejemplares similares
-
Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β
por: Straccia, Marco, et al.
Publicado: (2011) -
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2021) -
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
por: Valente, Tony, et al.
Publicado: (2017) -
Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis
por: Pulido-Salgado, Marta, et al.
Publicado: (2017) -
Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents
por: Gresa-Arribas, Núria, et al.
Publicado: (2012)